Literature DB >> 23052744

Long-term results of surgery for papillary thyroid carcinoma with local recurrence.

Hiroki Uchida1, Tsuneo Imai, Toyone Kikumori, Hironori Hayashi, Shigenori Sato, Sumiyo Noda, Ai Idota, Tetsuya Kiuchi.   

Abstract

PURPOSE: Surgical treatment of local recurrent papillary thyroid carcinoma is still controversial because of the increased morbidity in comparison to primary surgery, and the unclear efficacy. This study analyzed the efficacy and safety of surgery for recurrent disease.
METHODS: A retrospective cohort analysis of 86 patients who underwent surgery for local recurrent papillary thyroid carcinoma at a single institution during the period 1979-2009.
RESULTS: The cause-specific survival rates of all patients at 5, 10, and 20 years were 86 % (95 % CI 77-95 %), 74 % (95 % CI 62-87 %), and 36 % (95 % CI 18-54 %), respectively. A univariate analysis found that gender, age >45 years at reoperation and macroscopic non-curative surgery for recurrence affected the cause-specific survival rates. The latter two features remained significant in a multivariate analysis. Permanent recurrent nerve paralysis and hypoparathyroidism developed in 4 (4.7 %) and 5 (5.8 %) patients, respectively.
CONCLUSIONS: Surgery for local recurrent papillary thyroid carcinoma could be effective when macroscopic curative dissection was possible, and that the procedure was safe and was associated with minimal morbidity. Therefore, repeat surgery for local recurrent papillary thyroid carcinoma is worthwhile.

Entities:  

Mesh:

Year:  2012        PMID: 23052744     DOI: 10.1007/s00595-012-0353-z

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  25 in total

1.  Prognosis of patients with papillary thyroid carcinoma showing postoperative recurrence to the central neck.

Authors:  Yasuhiro Ito; Takuya Higashiyama; Yuuki Takamura; Kaoru Kobayashi; Akihiro Miya; Akira Miyauchi
Journal:  World J Surg       Date:  2011-04       Impact factor: 3.352

2.  Complications in thyroid surgery for carcinoma: one institution's surgical experience.

Authors:  Antonio Toniato; Isabella Merante Boschin; Andrea Piotto; Maria Rosa Pelizzo; Annamaria Guolo; Mirto Foletto; Eric Casalide
Journal:  World J Surg       Date:  2008-04       Impact factor: 3.352

Review 3.  Intraoperative monitoring of the recurrent laryngeal nerve during revision thyroid surgery.

Authors:  Samuel Johnson; David Goldenberg
Journal:  Otolaryngol Clin North Am       Date:  2008-12       Impact factor: 3.346

Review 4.  Papillary and follicular thyroid carcinoma.

Authors:  M J Schlumberger
Journal:  N Engl J Med       Date:  1998-01-29       Impact factor: 91.245

Review 5.  Well-differentiated thyroid cancer.

Authors:  G H Jossart; O H Clark
Journal:  Curr Probl Surg       Date:  1994-12       Impact factor: 1.909

6.  Is central neck dissection necessary for the treatment of lateral cervical nodal recurrence of papillary thyroid carcinoma?

Authors:  Jong-Lyel Roh; Jae-Yong Park; Ki Sang Rha; Chan Il Park
Journal:  Head Neck       Date:  2007-10       Impact factor: 3.147

7.  Resection and reconstruction of the airway in patients with advanced thyroid cancer.

Authors:  Kazuyasu Nakao; Kazushi Kurozumi; Masaaki Nakahara; Tetsuo Kido
Journal:  World J Surg       Date:  2004-11-04       Impact factor: 3.352

8.  Central lymph node dissection as a secondary procedure for papillary thyroid cancer: Is there added morbidity?

Authors:  Raul Alvarado; Mark S Sywak; Leigh Delbridge; Stan B Sidhu
Journal:  Surgery       Date:  2009-03-27       Impact factor: 3.982

9.  Efficacy of nodal dissection for treatment of persistent/recurrent papillary thyroid cancer.

Authors:  Kathryn G Schuff; Stephen M Weber; Babak Givi; Mary H Samuels; Peter E Andersen; James I Cohen
Journal:  Laryngoscope       Date:  2008-05       Impact factor: 3.325

10.  Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinoma.

Authors:  Gary L Clayman; Thomas D Shellenberger; Lawrence E Ginsberg; Beth S Edeiken; Adel K El-Naggar; Rena V Sellin; Steven G Waguespack; Dianna B Roberts; Anupam Mishra; Steven I Sherman
Journal:  Head Neck       Date:  2009-09       Impact factor: 3.147

View more
  5 in total

1.  Percutaneous Microwave Ablation of Metastatic Lymph Nodes from Papillary Thyroid Carcinoma: Preliminary Results.

Authors:  Wei Zhou; Yudong Chen; Lu Zhang; Xiaofeng Ni; Shangyan Xu; Weiwei Zhan
Journal:  World J Surg       Date:  2019-04       Impact factor: 3.352

Review 2.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

3.  Engineering Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to Selectively Target Papillary Thyroid Cancer Cells.

Authors:  Idit Dotan; Philip J R Roche; Miltiadis Paliouras; Elliot J Mitmaker; Mark A Trifiro
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

4.  Blood-Rich Enhancement in Ultrasonography Predicts Worse Prognosis in Patients With Papillary Thyroid Cancer.

Authors:  Luying Gao; Xuehua Xi; Qiong Gao; Jiajia Tang; Xiao Yang; Shenling Zhu; Ruina Zhao; Xingjian Lai; Xiaoyan Zhang; Bo Zhang; Yuxin Jiang
Journal:  Front Oncol       Date:  2021-01-08       Impact factor: 6.244

5.  The clinical significance of remnant thyroid tissue in thyroidectomized differentiated thyroid cancer patients on 131I-SPECT/CT.

Authors:  Feng Wang; Hui Nie; Wei Li; Rusen Zhang; Wen Li
Journal:  BMC Med Imaging       Date:  2021-05-08       Impact factor: 1.930

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.